Condition: Brain Diseases · Brain Diseases, Metabolic · Brain Diseases, Metabolic, Inborn · Sponsor: Rigshospitalet, Denmark
The overall aim of this study is to evaluate LNAA treatment as a potential alternative to conventional dietary treatment for PKU. This study investigates the effects of LNAA treatment compared to the classic dietary treatment on cerebral dopamine synthesis in patients with classic PKU. We will assess LNAAs effectiveness on neurotransmitter synthesis, cognitive function, mental health, and safety, compared to the standard diet.
This description comes directly from the study's public registry record.
Allan Lund, Professor, MD, DMSc · +4535451303 · allan.lund@regionh.dk
Olivia Fjellbirkeland, MD · olivia.welle.fjellbirkeland@regionh.dk
Always discuss trial participation with your own doctor first.
| Center for Inherited Metabolic Diseases | Copenhagen, Denmark | Recruiting |
| Copenhagen University Hospital, Rigshospitalet | Copenhagen, Denmark | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06337864